296 related articles for article (PubMed ID: 9379315)
1. Osteopontin antisense deoxyoligonucleotides inhibit bone resorption by mouse osteoclasts in vitro.
Tani-Ishii N; Tsunoda A; Umemoto T
J Periodontal Res; 1997 Aug; 32(6):480-6. PubMed ID: 9379315
[TBL] [Abstract][Full Text] [Related]
2. Autocrine regulation of osteoclast formation and bone resorption by IL-1 alpha and TNF alpha.
Tani-Ishii N; Tsunoda A; Teranaka T; Umemoto T
J Dent Res; 1999 Oct; 78(10):1617-23. PubMed ID: 10520966
[TBL] [Abstract][Full Text] [Related]
3. Human osteoclast and giant cell differentiation: the apparent switch from nonspecific esterase to tartrate resistant acid phosphatase activity coincides with the in situ expression of osteopontin mRNA.
Connor JR; Dodds RA; James IE; Gowen M
J Histochem Cytochem; 1995 Dec; 43(12):1193-201. PubMed ID: 8537635
[TBL] [Abstract][Full Text] [Related]
4. Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: an in vitro and ex vivo study of remodeling bone.
Dodds RA; Connor JR; James IE; Rykaczewski EL; Appelbaum E; Dul E; Gowen M
J Bone Miner Res; 1995 Nov; 10(11):1666-80. PubMed ID: 8592943
[TBL] [Abstract][Full Text] [Related]
5. Osteoclasts resorb protein-free mineral (Osteologic discs) efficiently in the absence of osteopontin.
Contractor T; Babiarz B; Kowalski AJ; Rittling SR; Sørensen ES; Denhardt DT
In Vivo; 2005; 19(2):335-41. PubMed ID: 15796195
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin posttranslational modifications, possibly phosphorylation, are required for in vitro bone resorption but not osteoclast adhesion.
Razzouk S; Brunn JC; Qin C; Tye CE; Goldberg HA; Butler WT
Bone; 2002 Jan; 30(1):40-7. PubMed ID: 11792563
[TBL] [Abstract][Full Text] [Related]
7. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin.
Lee SK; Goldring SR; Lorenzo JA
Endocrinology; 1995 Oct; 136(10):4572-81. PubMed ID: 7664679
[TBL] [Abstract][Full Text] [Related]
8. Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro.
Okazaki R; Toriumi M; Fukumoto S; Miyamoto M; Fujita T; Tanaka K; Takeuchi Y
Endocrinology; 1999 Nov; 140(11):5060-5. PubMed ID: 10537132
[TBL] [Abstract][Full Text] [Related]
9. Regulation of bone sialoprotein and osteopontin mRNA expression by dexamethasone and 1,25-dihydroxyvitamin D3 in rat bone organ cultures.
Chen J; Thomas HF; Sodek J
Connect Tissue Res; 1996; 34(1):41-51. PubMed ID: 8835847
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin mRNA expression during bone resorption: an in situ hybridization study of induced ectopic bone in the rat.
Arai N; Ohya K; Ogura H
Bone Miner; 1993 Aug; 22(2):129-45. PubMed ID: 8251765
[TBL] [Abstract][Full Text] [Related]
11. Expression of bone sialoprotein mRNA during bone formation and resorption induced by colchicine in rat tibial bone marrow cavity.
Arai N; Ohya K; Kasugai S; Shimokawa H; Ohida S; Ogura H; Amagasa T
J Bone Miner Res; 1995 Aug; 10(8):1209-17. PubMed ID: 8585425
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin K mRNA detection is restricted to osteoclasts during fetal mouse development.
Dodds RA; Connor JR; Drake F; Feild J; Gowen M
J Bone Miner Res; 1998 Apr; 13(4):673-82. PubMed ID: 9556067
[TBL] [Abstract][Full Text] [Related]
13. Effects of berberine on differentiation and bone resorption of osteoclasts derived from rat bone marrow cells.
Wei P; Jiao L; Qin LP; Yan F; Han T; Zhang QY
Zhong Xi Yi Jie He Xue Bao; 2009 Apr; 7(4):342-8. PubMed ID: 19361364
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin is required for mechanical stress-dependent signals to bone marrow cells.
Ishijima M; Tsuji K; Rittling SR; Yamashita T; Kurosawa H; Denhardt DT; Nifuji A; Ezura Y; Noda M
J Endocrinol; 2007 May; 193(2):235-43. PubMed ID: 17470514
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin expression by osteoclast and osteoblast progenitors in the murine bone marrow: demonstration of its requirement for osteoclastogenesis and its increase after ovariectomy.
Yamate T; Mocharla H; Taguchi Y; Igietseme JU; Manolagas SC; Abe E
Endocrinology; 1997 Jul; 138(7):3047-55. PubMed ID: 9202251
[TBL] [Abstract][Full Text] [Related]
16. A novel culture system to generate osteoclasts and bone resorption using porcine bone marrow cells: role of M-CSF.
Scheven BA; Milne JS; Robins SP
Biochem Biophys Res Commun; 1997 Feb; 231(1):231-5. PubMed ID: 9070255
[TBL] [Abstract][Full Text] [Related]
17. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
[TBL] [Abstract][Full Text] [Related]
18. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
19. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
Kudo O; Sabokbar A; Pocock A; Itonaga I; Athanasou NA
Calcif Tissue Int; 2002 Dec; 71(6):539-46. PubMed ID: 12232680
[TBL] [Abstract][Full Text] [Related]
20. Effects of vascular endothelial growth factor-C and -D on osteoclast differentiation and function in human peripheral blood mononuclear cells.
Motokawa M; Tsuka N; Kaku M; Kawata T; Fujita T; Ohtani J; Matsuda Y; Terao A; Tanne K
Arch Oral Biol; 2013 Jan; 58(1):35-41. PubMed ID: 22771550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
